IDNA.US iShares Genomics Immunology and Healthcare ETF

- USD
No recent price
Total assets
354M
Expense ratio
0.47%
Dividend yield
0.66%
1-year return
+69.51%
Holdings
47
Since
2019

Fund data as reported by the issuer, updated Nov 15, 2026. Total assets are in the fund's base currency.

What does IDNA.US invest in?

  • Mostly US stocks (70.1%)
  • Largest sector: Healthcare (100.0%)
  • Largest region: North America (72.4%)
  • Top 3 holdings: 24.1% of the fund

Asset allocation

  • US stocks 70.1%
  • Non-US stocks 31.8%
  • Cash 0.2%

Top holdings

All holdings, sectors and regions

iShares Genomics Immunology and Healthcare ETF performance

Sharpe ratio 1.25
This year
+65.51%
1 year
+69.51%
3 years
+33.45%
5 years
-1.36%

Volatility 29.2% over 1 year and 23.9% over 3 years. High: expect large swings.

Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers

IDNA.US price

Prices on the chart can differ slightly from the closing prices StockSummer shows.

About iShares Genomics Immunology and Healthcare ETF

The fund generally will invest at least 80% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, …

Full fund profile